Structure of the Adenosine A1 Receptor Reveals the Basis for Subtype Selectivity

被引:225
作者
Glukhova, Alisa [1 ]
Thal, David M. [1 ]
Nguyen, Anh T. [1 ]
Vecchio, Elizabeth A. [1 ]
Jorg, Manuela [2 ]
Scammells, Peter J. [2 ]
May, Lauren T. [1 ]
Sexton, Patrick M. [1 ]
Christopoulos, Arthur [1 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia
[2] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic 3052, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
PROTEIN-COUPLED RECEPTOR; 2ND EXTRACELLULAR LOOP; ACUTE HEART-FAILURE; A(2A) RECEPTOR; ALLOSTERIC MODULATION; MOLECULAR-DYNAMICS; ADENOSINE-A1-RECEPTOR BINDING; CRYSTAL-STRUCTURES; FORCE-FIELDS; DRUG DESIGN;
D O I
10.1016/j.cell.2017.01.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenosine A(1) receptor (A(1)-AR) is a G-proteincoupled receptor that plays a vital role in cardiac, renal, and neuronal processes but remains poorly targeted by current drugs. We determined a 3.2 angstrom crystal structure of the A(1)-AR bound to the selective covalent antagonist, DU172, and identified striking differences to the previously solved adenosine A(2A) receptor (A(2A)-AR) structure. Mutational and computational analysis of A(1)-AR revealed a distinct conformation of the second extracellular loop and a wider extracellular cavity with a secondary binding pocket that can accommodate orthosteric and allosteric ligands. We propose that conformational differences in these regions, rather than amino-acid divergence, underlie drug selectivity between these adenosine receptor subtypes. Our findings provide a molecular basis for AR subtype selectivity with implications for understanding the mechanisms governing allosteric modulation of these receptors, allowing the design of more selective agents for the treatment of ischemia-reperfusion injury, renal pathologies, and neuropathic pain.
引用
收藏
页码:867 / +
页数:24
相关论文
共 69 条
[1]   Microscale fluorescent thermal stability assay for membrane proteins [J].
Alexandrov, Alexander I. ;
Mileni, Mauro ;
Chien, Ellen Y. T. ;
Hanson, Michael A. ;
Stevens, Raymond C. .
STRUCTURE, 2008, 16 (03) :351-359
[2]   Allosteric Modulators of the Adenosine A1 Receptor: Synthesis and Pharmacological Evaluation of 4-Substituted 2-Amino-3-benzoylthiophenes [J].
Aurelio, Luigi ;
Valant, Celine ;
Flynn, Bernard L. ;
Sexton, Patrick M. ;
Christopoulos, Arthur ;
Scammells, Peter J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) :4543-4547
[3]   Critical role for the second extracellular loop in the binding of both orthosteric and allosteric g protein-coupled receptor Ligands [J].
Avlani, Vimesh A. ;
Gregory, Karen J. ;
Morton, Craig J. ;
Parker, Michael W. ;
Sexton, Patrick M. ;
Christopoulos, Arthur .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (35) :25677-25686
[4]  
Ballesteros J. A., 1995, Neuroscience Methods, P366, DOI [DOI 10.1016/S1043-9471, DOI 10.1016/S1043-9471(05)80049-7]
[5]   Quantification of adenosine A1 receptor biased agonism: Implications for drug discovery [J].
Baltos, Jo-Anne ;
Gregory, Karen J. ;
White, Paul J. ;
Sexton, Patrick M. ;
Christopoulos, Arthur ;
May, Lauren T. .
BIOCHEMICAL PHARMACOLOGY, 2016, 99 :101-112
[6]   Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A1-adenosine receptor [J].
Beauglehole, AR ;
Baker, SP ;
Scammells, PJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) :4973-4980
[7]   SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information [J].
Biasini, Marco ;
Bienert, Stefan ;
Waterhouse, Andrew ;
Arnold, Konstantin ;
Studer, Gabriel ;
Schmidt, Tobias ;
Kiefer, Florian ;
Cassarino, Tiziano Gallo ;
Bertoni, Martino ;
Bordoli, Lorenza ;
Schwede, Torsten .
NUCLEIC ACIDS RESEARCH, 2014, 42 (W1) :W252-W258
[8]   Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor [J].
Bokoch, Michael P. ;
Zou, Yaozhong ;
Rasmussen, Soren G. F. ;
Liu, Corey W. ;
Nygaard, Rie ;
Rosenbaum, Daniel M. ;
Fung, Juan Jose ;
Choi, Hee-Jung ;
Thian, Foon Sun ;
Kobilka, Tong Sun ;
Puglisi, Joseph D. ;
Weis, William I. ;
Pardo, Leonardo ;
Prosser, R. Scott ;
Mueller, Luciano ;
Kobilka, Brian K. .
NATURE, 2010, 463 (7277) :108-U121
[9]   Clinical Efforts to Reduce Myocardial Infarct Size-The Next Step [J].
Braunwald, Eugene .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 16 (3-4) :349-353
[10]  
BRUNS RF, 1990, MOL PHARMACOL, V38, P950